艾媒咨询 | 2025年中国数字健康管理行业发展状况与用户行为调查数据

在技术革新与健康意识觉醒的双重驱动下，中国数字健康管理行业进入高速发展期。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国数字健康管理行业发展状况与用户行为调查数据》数据显示，2024年中国体检市场规模为2374.3亿元，中国体检行业市场规模呈现稳定增长态势。在2025年中国健康管理平台用户使用健康管理类App原因中，改善睡眠质量的占比最高，达到63.57%；体型管理和促进肠道健康的占比分别位列第二和第三，分别为44.30%和40.09%。这说明睡眠质量、体型管理和肠道健康是健康管理平台用户使用健康管理App的主要原因。在2025年中国健康管理平台用户认为影响选择App的因素中，食物营养管理分析以46.73%的比例成为最突出的因素，显示出健康管理平台用户对营养管理的高度重视。其次，有免费的健身课程占比41.20%，有比较优惠的健身课程占比39.31%，显示出健康管理平台用户对健康管理App的功能性和实用性有较高要求。艾媒咨询分析师认为，未来中国数字健康管理行业将呈现三大趋势：技术上，AI诊断、可穿戴设备与 5G 远程监测加速落地，推动健康管理精准化；场景上，家庭健康监测、企业健康管理、社区养老服务等成为新增长点；生态上，“数字健康+保险+医疗” 跨界融合模式成熟，通过数据共享实现多方共赢。企业需聚焦用户体验与技术合规，在政策支持与消费需求驱动下，构建更具竞争力的数字健康生态。
Driven by both technological innovation and the awakening of health awareness, China's digital health management industry has entered a period of rapid development. According to the latest "Survey data on the development status and user behavior of China's digital health management industry in 2025" released by iiMedia Research, a world-leading third-party data mining and analysis institution for the new economy industry, the market size of China's physical examination industry shows a stable growth trend. The market size of physical examinations was 46.83 billion yuan in 2012, increasing to 59.26 billion yuan in 2013. Since then, it has been steadily growing every year, reaching 225.05 billion yuan in 2023 and climbing to 237.43 billion yuan in 2024. In the future, with the continuous enhancement of people's health awareness, the improvement of consumption capacity and the advancement of medical technology, the demand for physical examinations will continue to be released. The market size of China's physical examination industry is expected to maintain a growth trend in the future. Among the reasons why users of health management platforms in China used health management apps in 2025, the proportion of improving sleep quality was the highest, reaching 63.57%. The proportions of body shape management and promoting intestinal health ranked second and third respectively, being 44.30% and 40.09% respectively.This indicates that sleep quality, body shape management and intestinal health are the main reasons why users of health management platforms use health management apps. In 2025, among the factors that Chinese health management platform users believed influenced their choice of apps, the analysis of food nutrition management accounted for 46.73%, becoming the most prominent factor, demonstrating the high attention that health management platform users attach to nutrition management. Secondly, the proportion of free fitness courses is 41.20%, and the proportion of relatively favorable fitness courses is 39.31%, indicating that users of the health management platform have high requirements for the functionality and practicality of the health management App. Analysts from iiMedia Research believe that the industry will present three major trends in the future: Technically, AI diagnosis, wearable devices and 5G remote monitoring are accelerating their implementation, promoting the precision of health management; In terms of scenarios, family health monitoring, enterprise health management, and community elderly care services have become new growth points. Ecologically, the cross-border integration model of "digital health + insurance + medical care" is mature, achieving a win-win situation for all parties through data sharing. Enterprises need to focus on user experience and technical compliance, and build a more competitive digital health ecosystem driven by policy support and consumer demand.

艾媒咨询 | 2025年中国夜间用药市场发展状况与消费者行为调查数据

在消费观念升级与健康意识觉醒的双重驱动下，中国夜间用药市场正迎来结构性变革。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国夜间用药市场发展状况与消费者行为调查数据》数据显示，2024年人均医疗保健支出为2547元。未来，随着科技进步带来医疗服务与产品的升级，中国人均医疗保健支出有望继续保持增长趋势。在2025年中国夜间用药消费者夜间购药药品种类中，感冒发烧药品占比31.22%，是所有药品中占比最高的。肠胃消化药品夜间购药占比第二，达到25.04%。整体来看，夜间购药以感冒发烧和肠胃消化等常见病症药品为主。在2025年中国夜间用药消费者夜间线上买药原因中，“夜间外出买药不安全”，达到63.51%。其次是“有些药品不好意思直接买/保护购药者隐私”，占比43.24%，说明夜间线上买药的安全性和隐私保护是夜间用药消费者的主要考虑因素。艾媒咨询分析师认为，未来中国夜间用药市场将呈现三大趋势：一是产品向天然成分、低副作用方向迭代，中药夜间用药市场潜力有望进一步释放；二是渠道融合加速，线上线下一体化的 “夜间健康服务圈” 将成为主流；三是智能化服务深化，通过 AI 问诊、智能药盒等技术提升用药安全性与便利性。企业需聚焦细分场景需求，加强产品创新与服务赋能，推动夜间用药市场向规范化、专业化方向发展。
Driven by the dual impetus of the upgrading of consumption concepts and the awakening of health awareness, the night-time medication market in China is undergoing a structural transformation. According to the latest "iiMedia Report | Survey data on the development status and consumer behavior of China's nighttime medication market in 2025" released by iiMedia Research, a leading third-party data mining and analysis institution for the new economy industry worldwide, the per capita healthcare expenditure in 2024 was 2,547 yuan. In the future, with the upgrading of medical services and products brought about by technological progress, China's per capita healthcare expenditure is expected to continue to grow. In 2025, among the types of medicines purchased by Chinese consumers at night, cold and fever medicines accounted for 31.22%, which was the highest proportion among all medicines. The proportion of night-time purchases of gastrointestinal digestion drugs ranked second, reaching 25.04%. Overall, when purchasing medicine at night, the main focus is on common conditions such as colds, fevers, and gastrointestinal disorders. Among the reasons why Chinese consumers purchase medicine online at night in 2025, "It is not safe to buy medicine outside at night" accounted for 63.51%. The second is "Some medicines are too embarrassing to be purchased directly/protecting the privacy of the purchasers", accounting for 43.24%, indicating that the safety and privacy protection of online medicine purchases at night are the main considerations for consumers taking medicine at night. Analysts from iiMedia Research believe that the future night medicine market in China will present three major trends: First, products will evolve towards natural ingredients and low side effects, and the potential of the traditional Chinese medicine night medicine market is expected to be further released; Second, the integration of channels is accelerating, and the "nighttime health service circle" that integrates online and offline will become the mainstream. Third, intelligent services have been deepened, and the safety and convenience of medication have been enhanced through technologies such as AI consultation and smart medicine boxes. Enterprises need to focus on the demands of specific scenarios, enhance product innovation and service empowerment, and promote the development of the night medication market towards standardization and professionalization.

2012-2013年中国移动医疗市场年度报告

本报告是由艾媒咨询行业分析专家领衔撰写，主要分析了该行业的市场规模、发展现状与投资前景，同时对该行业的未来发展作出科学的趋势预测和专业的行业数据分析，帮助客户评估该行业的投资价值。

艾媒咨询 | 2025年中国互联网医疗行业消费行为调查数据

随着互联网医疗服务的深度融合创新，其应用场景持续拓展深化，广泛应用于以在线问诊、慢性病管理为代表的基础医疗领域，以健康咨询、药品配送为核心的便民服务领域，以及AI辅助诊断、远程多学科会诊等技术赋能领域。同时，用户需求驱动服务形态升级，覆盖从以智能预检分诊为主的诊前准备阶段，到以电子病历共享为核心的诊中协作阶段，再到以个性化康复指导为特色的诊后管理全流程。在技术支撑层面，5G+医疗、区块链电子处方等创新应用正重构医疗服务体系，形成线上线下协同发展的新型医疗生态。全球新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国互联网医疗行业消费行为调查数据》数据显示，89.77%的受访者都体验过互联网医疗服务，每周使用一次的互联网医疗用户占比达到50.77%，消费者大多通过社交媒体广告接触到互联网医疗，在消费者中有46.91%的人选择了健康管理服务。在互联网医疗用户选择的医疗平台中，丁香医生平台无论是在使用量还是评分上都位居榜首，但互联网医疗用户在使用这些在线医疗平台时也会有顾虑，比如医学信息真假难辨等问题。艾媒咨询分析师认为，政府应与相关平台负责人合作，共同落实完善在线医疗平台的法律法规和各种制度，了解互联网医疗用户使用在线医疗平台的痛点并针对性改善，探索更多互联网医疗用户的使用需求并满足，才能使这个新兴的市场逐步扩大。
With the deep integration and innovation of Internet medical services, its application scenarios continue to expand and deepen, and it is widely used in the basic medical field represented by online consultation and chronic disease management, the convenient service field with health consultation and drug distribution as the core, and the technology enabling field such as AI-assisted diagnosis and remote multidisciplinary consultation. At the same time, user demand drives the upgrading of service forms, covering the whole process from the pre-diagnosis preparation stage based on intelligent pre-examination and triage, to the consultation collaboration stage based on electronic medical record sharing, and then to the post-diagnosis management featuring personalized rehabilitation guidance. At the technical support level, innovative applications such as 5G+ medical treatment and blockchain electronic prescription are reconstructing the medical service system, forming a new medical ecology with coordinated development online and offline. According to the latest survey Data of China's Internet Medical Industry Consumption Behavior in 2025 released by iiMedia Research, Survey data of consumer behavior in China's internet medical industry in 2025, 89.77% of the respondents have experienced Internet medical services. The proportion of Internet medical users who use it once a week reaches 50.77%. Consumers are mostly exposed to Internet medical through social media advertisements, and 46.91% of them choose health management services. Among the medical platforms selected by Internet medical users, Lilac Doctor platform ranks first in terms of usage and score, but Internet medical users also have concerns when using these online medical platforms, such as the difficulty in distinguishing between true and false medical information. Imedia Consulting analysts believe that the government should cooperate with the relevant platform leaders to jointly implement and improve the laws and regulations and various systems of online medical platforms, understand the pain points of Internet medical users using online medical platforms and make targeted improvements, explore and meet the use needs of more Internet medical users, in order to gradually expand this emerging market.

艾媒咨询：2015年中国“互联网+”社区研究报告

本报告是由艾媒咨询行业分析专家领衔撰写，主要分析了该行业的市场规模、发展现状与投资前景，同时对该行业的未来发展作出科学的趋势预测和专业的行业数据分析，帮助客户评估该行业的投资价值。

艾媒咨询|2021年中国医美机构市场竞争态势及企业营销模式分析报告

本报告研究涉及企业/品牌/案例：华韩整形，瑞丽医美，美莱整形，医思健康

数据显示，2016—2020年中国医美行业市场规模五年平均增长率为12.8%，与此同时，中国医美市场用户规模增长了4倍多。在人们生活水平的提升、年轻一代对医美的接受度的提高、政府监管层对医美行业的整治给医美消费者信心的提升的综合作用下，预计中国医美市场规模在2022年将达到2232亿元。随着医美产品及仪器技术水平提升、医美知识普及等，民众对整形美容的观念正在向积极态度转变，在整个行业扩张的过程中，轻医美的受众面广、门槛低、复购率高，更有可能提升市场整体渗透率，成为我国医美行业的主要增量市场。
According to the data, from 2016 to 2020, the five-year average growth rate of the market scale of China's medical and American industry was 12.8%. At the same time, the user scale of China's medical and American market increased by more than four times. Under the combined effect of the improvement of people's living standards, the improvement of the acceptance of medical beauty by the younger generation, the regulation of the medical beauty industry by the government regulators and the improvement of medical beauty consumer confidence, it is expected that the scale of China's medical beauty market will reach 223.2 billion yuan in 2022. With the improvement of the technical level of medical beauty products and instruments and the popularization of medical beauty knowledge, people's concept of plastic beauty is changing to a positive attitude. In the process of the expansion of the whole industry, light medical beauty has a wide audience, low threshold and high repurchase rate, which is more likely to improve the overall penetration rate of the market and become the main incremental market of China's medical beauty industry.

艾媒咨询|2020年中国养老产业典型模式及城市案例数据监测分析

本报告研究涉及企业/品牌/案例：上海养老模式、北京养老模式、重庆养老模式。

2020年6月5日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020年中国养老产业典型模式及城市案例数据监测分析》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对上海、北京、重庆等养老产业进行典型案例分析，并且结合美国、日本等西方发达国家经验，对当前中国的养老产业进行全面分析，判断2020-2021年中国养老产业的发展趋势。当前全球老龄化形式严峻，未来中国老龄化程度会进一步加大。国家越来越重视养老产业的发展，发布了一系列政策，支持社区养老模式革新、医养结合深化、智慧养老推进和养老金融市场开放等多个方向改革与开发，推动了养老产业发展。

As the aging population worsens, China's old-age dependency ratio (which shows how many older people per 100 working-age people) is 19.6% in 2019, the largest increase in 11 years. In 2019, the number of provinces with deep aging increased to seven, with Shanghai the most aging.

艾媒报告丨2016-2017中国移动医疗健康市场研究报告

iiMedia Research(艾媒咨询)数据显示，iiMedia Research(艾媒咨询)数据显示，中国移动医疗健康市场用户规模稳步增长，2016年第四季度接近3.0亿，与2015年相比，增长16.0%。

和佳医疗：2021年第三季度报告

艾媒咨询|2021年中国轻医美行业研究及产业链分析报告

本报告研究涉及企业/品牌/案例：爱美客，华熙生物，奇致激光，华韩整形，新氧，兰州生物

数据显示，2020年中国轻医美用户市场规模达到1520万人，预计到2021年将增至1813万人。在消费意识觉醒和消费需求驱动下，机构、医生在供给端强势助推轻医美行业更快速发展，预计2021年中国轻医美市场将达到798亿元，同比增长46.4%。在行业快速增长的同时，轻医美产业链各环节企业由于集中度不同导致利润分配不均，具体来看，上游原料耗材企业由于高技术壁垒，市场集中度较高，毛利率高于中下游企业，如知名玻尿酸、肉毒素产品制造企业爱美客、华熙生物等，而中下游由于竞争分散，单体获利参差不齐，更容易产生乱象。但总体来说，在行业监管加强、机构自律、平台监督等多方力量共同作用下，轻医美行业将会向线上化、品牌化、规范化发展。
According to the data, the market size of China's light medical beauty users will reach 15.2 million in 2020, and it is expected to increase to 18.13 million by 2021. Driven by the awakening of consumer awareness and consumer demand, institutions and doctors strongly boost the rapid development of light medical beauty industry in the supply side. It is estimated that China's light medical beauty market will reach 79.8 billion yuan in 2021, with a year-on-year growth of 46.4%. With the rapid growth of the industry, the profit distribution of enterprises in each link of the light medical beauty industry chain is uneven due to different concentration. Specifically, due to high technical barriers, the upstream raw materials and consumables enterprises have higher market concentration and higher gross profit rate than the middle and downstream enterprises, such as the well-known hyaluronic acid, botulinum toxin product manufacturing enterprises aimekke, Huaxi biology, etc., while the middle and downstream enterprises have higher gross profit rate due to scattered competition, Individual profit is uneven, more likely to produce chaos. But on the whole, under the joint action of industry supervision, institutional self-discipline, platform supervision and other forces, the light medical beauty industry will develop to online, brand and standardization.